# India Genetic Testing Market

> India Genetic Testing Market Research Report: Size, Share, Trend Analysis By Types (Molecular Genetic Tests/ DNA Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests, Others), By Types (Prescribed Genetic Testing, Direct-to-Consumer Genetic Testing), and By Applications (Reproductive Health, Cancer Screening Ancestry, Predictive and Pre-Symptomatic Testing, Others) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 18.82%
- **2024:** $ 665 Million
- **2025:** $ 790.15 Million
- **2035:** $ 4,432.15 Million
- **Key Players:** Illumina (US), Thermo Fisher Scientific (US), Myriad Genetics (US), 23andMe (US), Genomic Health (US), Fulgent Genetics (US), Natera (US), Guardant Health (US)

**Report ID:** MRFR/LS/43271-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/india-genetic-testing-market-44951

---

## Market Summary

## **India Genetic Testing Market Overview**

As per MRFR analysis, the India Genetic Testing Market Size was estimated at 448.0 (USD Million) in 2023.The India Genetic Testing Market Industry is expected to grow from 532.0(USD Million) in 2024 to 2,128.0 (USD Million) by 2035. The India Genetic Testing Market CAGR (growth rate) is expected to be around 13.431% during the forecast period (2025 - 2035)

**Key India Genetic Testing Market Trends Highlighted**

The India Genetic Testing Market is witnessing significant growth driven by various key market drivers. A rise in awareness about genetic disorders and the benefits of early detection is encouraging more individuals to seek genetic testing services. Additionally, the Indian government is promoting personalized medicine through initiatives and policies aimed at improving healthcare infrastructure. Awareness campaigns about lifestyle-related genetic risks are further contributing to the increased utilization of genetic tests.

Opportunities to be explored in this market include the expansion of genetic testing services in rural areas and tier-2 cities, where healthcare access has been limited.Collaborations between public health systems and private companies can help in extending genetic testing services, tailored to local populations' needs. Moreover, advancements in technology, such as the reduction in costs of genome sequencing, present prospects for wider adoption of these tests among the general public. Recent trends indicate that there is a growing interest in preventive healthcare and wellness among Indians, leading to a higher demand for genetic tests aimed at preventing hereditary diseases.

The trend is reinforced by the increasing integration of artificial intelligence in genetic testing services, which enhances the accuracy and efficiency of tests.Parents are increasingly opting for prenatal genetic screening options to understand potential genetic disorders in their unborn children, showcasing a shift towards proactive healthcare. Overall, the India Genetic Testing Market is evolving with these trends, reflecting a positive approach towards health management and inherent genetic risks.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**India Genetic Testing Market Drivers**

**Increasing Prevalence of Genetic Disorders**

The rising incidence of genetic disorders in India is a significant driver for the India Genetic Testing Market Industry. Reports suggest that approximately 1 in 20 individuals in India is expected to be affected by a genetic disorder, with certain conditions, such as thalassemia and sickle cell disease, showing increasing prevalence.

The Indian government, through initiatives led by bodies like the Ministry of Health and Family Welfare, is also focusing on early diagnosis and intervention for genetic conditions.This focus underscores the necessity for genetic testing to facilitate timely treatment and management of these disorders, which contributes to the market's growth potential. Furthermore, research indicates a 15% increase in the number of diagnosed genetic disorders, further establishing a pressing need for genetic testing solutions. The presence of established organizations like Apollo Hospitals and Fortis Healthcare, which are investing in advanced genetic testing technologies, enhances this growing market demand.

**Growing Awareness and Acceptance of Genetic Testing**

There is a notable increase in awareness regarding the benefits of genetic testing among the Indian population. Increased health campaigns and educational programs by organizations such as the Indian Council of Medical Research (ICMR) play a fundamental role in dispelling myths and enhancing understanding of genetic testing. An upward trend shows that in the last five years, nearly 30% more people are opting for genetic counseling and testing, driven by improved accessibility to information.This rising acceptance directly impacts the growth dynamics of the India Genetic Testing Market Industry, making it easier for individuals to make informed health decisions.

Educational institutions and medical organizations are actively promoting genetic testing, uncovering its role in personalized healthcare, thereby encouraging a shift in societal perspectives towards these advanced diagnostics.

**Technological Advancements in Genetic Testing**

Technological innovation in genetic testing methodologies is propelling the growth of the India Genetic Testing Market Industry. The advent of Next-Generation Sequencing (NGS) technology has dramatically decreased testing costs and turnaround times, making genetic testing more accessible to the average Indian. According to recent studies, the adoption rate of NGS in India has surged by over 50% in the past three years, indicating a shift towards more sophisticated and efficient testing methods.Organizations such as BGI Genomics and MedGenome are at the forefront of adopting these technologies, enhancing the precision and reliability of genetic tests.

This rise in technological uptake aligns with the Indian government's push for modernization in healthcare infrastructure, ensuring that advanced genetic testing remains a cornerstone of preventive healthcare strategies.

**Legislative and Policy Support for Genetic Testing**

The Indian government is actively promoting genetic testing through favorable policies and legislative frameworks. The National Health Policy of 2017 emphasizes the need for genetic research and personalized medicine, providing a conducive environment for the growth of the India Genetic Testing Market Industry. With the government's emphasis on healthcare access and affordable treatment, there has been a significant increase in funding and support for genetic testing initiatives.Data shows that funding for healthcare research, including genetic testing, has increased by over 20% during the last budget cycle.

The proactive stance of Indian regulatory bodies, including the Central Drugs Standard Control Organization (CDSCO), ensures that genetic testing services meet strict safety and efficacy standards, further fostering public trust and encouraging demand for genetic testing in India.

**India Genetic Testing Market Segment Insights**

**Genetic Testing Market Type Insights**

The India Genetic Testing Market has seen substantial growth, driven by the increasing awareness of personalized medicine and preventive healthcare. The Type segment, which encompasses Molecular Genetic Tests/DNA Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests, and others, plays a crucial role in the landscape of genetic testing in the country. Molecular Genetic Tests, commonly referred to as DNA tests, are significant due to their ability to identify genetic disorders at an early stage, which helps in prompt diagnosis and management of diseases.

This segment is essential for its application in various fields, including oncology and prenatal testing, thus contributing positively to patient outcomes and overall healthcare costs.

Chromosomal Genetic Tests involve analyzing chromosomes to detect anomalies that might lead to genetic diseases or developmental delays. This testing type is instrumental in reproductive health, particularly for couples with a history of genetic disorders or those undergoing assisted reproductive technologies. Biochemical Genetic Tests assess a person’s metabolic function and are integral for detecting inborn errors of metabolism, allowing for early intervention that can save lives. The "Others" category encompasses a range of tests that don't fall strictly into the previous categories, offering tailored solutions for specific genetic conditions.

These segments not only showcase advancements in genetic testing technology but also reflect the growing acceptance of these tests among healthcare providers and patients within India. The government has been actively promoting genetic testing as a pathway to improve health outcomes nationwide, contributing to an increase in the overall acceptance and utilization of these technologies. The India Genetic Testing Market is set to thrive as advances in genomic research continue to grow, providing ample opportunities for better healthcare solutions while addressing the diverse genetic health needs of the population.

Furthermore, the market dynamics are also influenced by regulatory developments, consumer awareness, and the expansion of healthcare infrastructure, all of which impact the Type segment's contributions to the overall market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Genetic Testing Market Type Insights**

The India Genetic Testing Market is experiencing notable segmentation into various types, primarily focusing on Prescribed Genetic Testing and Direct-to-Consumer Genetic Testing. Prescribed Genetic Testing plays a crucial role as it is often utilized in clinical settings, aiding healthcare professionals in diagnosing genetic disorders and tailoring personalized treatment plans to patients. This segment reflects the increasing awareness and acceptance of genetic disorders in India, fostering a proactive approach to healthcare.

On the other hand, Direct-to-Consumer Genetic Testing has gained significant traction, driven by growing consumer interest in genetic information for personalized insights regarding health, ancestry, and traits.This segment empowers individuals to take charge of their health decisions but also raises questions surrounding privacy and data security. The overall India Genetic Testing Market revenue is poised for growth, supported by advancements in technology, wider accessibility of testing services, and an increasing demand for preventive healthcare solutions.

With the rise of both segments, the market is likely to provide valuable opportunities and insights for stakeholders, marking a transformational phase in India's healthcare landscape.

**Genetic Testing Market Application Insights**

The Application segment of the India Genetic Testing Market encompasses a diverse array of uses that significantly impact healthcare delivery in the region. Among these, Reproductive Health plays a crucial role in enabling prospective parents to make informed decisions concerning genetic disorders, thereby enhancing family planning initiatives. Cancer Screening stands out for its importance in early detection, offering a proactive approach to managing cancer risks for the population.

Ancestry testing attracts considerable interest, as it assists individuals in tracing their lineage and understanding their genetic heritage, reflecting societal trends toward personal identity and cultural connections.Predictive and Pre-Symptomatic Testing also holds substantial relevance, as it empowers individuals to assess their risk for inherited conditions, facilitating preventive health measures. The 'Others' category captures emerging applications, showcasing the evolving landscape of the genetic testing field in India is greatly influenced by technological advancements, rising healthcare awareness, and a growing emphasis on personalized medicine.

Overall, the integration of genetic testing in these applications aligns with the Indian government's focus on enhancing healthcare services and improving health outcomes, reflecting a shift towards innovative healthcare solutions.

**India Genetic Testing Market Key Players and Competitive Insights**

The competitive landscape of the India Genetic Testing Market has been evolving significantly, driven by advancements in technology, increased awareness about genetic testing, and a growing demand for personalized medicine. The market comprises various players, ranging from established healthcare giants to new entrants focusing on innovative diagnostic solutions. Companies in this sector are continually investing in research and development, strategic partnerships, and acquisitions to enhance their service offerings and improve accuracy in testing.

As the awareness of genetic disorders and hereditary diseases rises among the Indian population, the market is expected to witness an increase in demand for comprehensive genetic testing solutions. The competitive dynamics are characterized by a wide variety of testing services, including prenatal screening, carrier testing, pharmacogenomics, and oncology testing, which cater to both healthcare providers and consumers. This competition fosters innovation, leading to more accessible and efficient testing facilities tailored diverse patient needs.LabCorp is a prominent player within the Indian Genetic Testing Market, known for its comprehensive suite of lab testing services.

The company focuses on providing high-quality genetic testing solutions, greatly enhancing its presence in the region through a network of state-of-the-art laboratories and strategic alliances with healthcare institutions. LabCorp's strengths lie in its commitment to technological advancement and the implementation of data analytics in genetic testing processes. Their internationally recognized methodologies ensure reliable results for patients and healthcare providers alike, fostering trust and accuracy in testing.

With a robust infrastructure and highly trained workforce, LabCorp is well-positioned to address the specific genetic testing needs of the Indian population, making it a significant competitor in this growing market.Aarav Unmanned Systems is another notable entity in the Indian Genetic Testing Market, focusing on deploying advanced technologies to innovate healthcare solutions. Although primarily recognized for its expertise in unmanned systems technology, the company has ventured into genetic testing by developing applications that aid in diagnostic procedures. Aarav Unmanned Systems offers key products aimed at streamlining genetic testing processes, ensuring that testing is not only efficient but also accurate.

This diversification reflects the company's strategic approach to expand its market presence through the integration of technology in healthcare. With its strengths in automation and data collection, Aarav Unmanned Systems positions itself uniquely in the market. The company is also actively exploring mergers and acquisitions to enhance its capabilities and expand its offerings in genetic testing, thus benefiting the dynamic landscape of genetic diagnostics in India while catering to the increasing demand for innovative testing solutions.

**Key Companies in the India Genetic Testing Market Include**

**India Genetic Testing Market Industry Developments**

The India Genetic Testing Market has witnessed notable advancements, particularly with the increasing integration of advanced technologies in diagnostic tools. Companies like LabCorp and Thermo Fisher Scientific are enhancing their capabilities to meet the rise in consumer demand for genetic tests driven by the growing prevalence of genetic disorders. In August 2023, MedGenome raised significant funding to expand its genetic testing services, which is expected to bolster their market presence.

Furthermore, in June 2023, Roche announced a collaboration with Narayana Health to offer advanced genetic testing solutions in India, enhancing accessibility for patients. The market has also seen substantial growth in valuation as the Indian government focuses on improving healthcare infrastructure and personalized medicine initiatives. In 2021, Mylab Discovery Solutions launched a new range of genetic tests, aligning with the increasing emphasis on preventive healthcare. Companies like Mapmygenome and Qiagen are also stepping up their product offerings, capitalizing on India's expanding healthcare market.

As of October 2023, the sector continues to flourish, reflecting an overall optimistic outlook driven by innovation and strategic partnerships among key players in this dynamic environment.

**India Genetic Testing Market Segmentation Insights**

## Market Drivers

### Government Initiatives and Funding

Government support plays a pivotal role in the growth of the genetic testing market. Various initiatives aimed at enhancing healthcare infrastructure and funding for genetic research are being implemented. The Indian government has allocated substantial resources to promote genetic testing, particularly in rural areas where access to healthcare is limited. This funding is likely to facilitate the establishment of more testing facilities and increase public awareness about the benefits of genetic testing. As a result, the genetic testing market is anticipated to experience a surge in demand, driven by improved accessibility and affordability of testing services.

### Advancements in Genetic Technologies

Technological innovations in genetic testing methodologies are significantly influencing the genetic testing market. The introduction of next-generation sequencing (NGS) and CRISPR technology has revolutionized the accuracy and efficiency of genetic tests. These advancements allow for comprehensive genomic analysis, which is essential for personalized medicine. In India, the cost of genetic testing has decreased by nearly 30% due to these technological improvements, making it more accessible to the general population. As laboratories adopt these cutting-edge technologies, the genetic testing market is expected to expand, catering to a broader demographic and enhancing diagnostic capabilities.

### Rising Prevalence of Genetic Disorders

The increasing incidence of genetic disorders in India is a crucial driver for the genetic testing market. With an estimated 6-8 million people affected by genetic conditions, the demand for early diagnosis and intervention is growing. Genetic testing enables healthcare providers to identify hereditary diseases, allowing for timely treatment and management. This trend is further supported by the Indian government's initiatives to promote genetic research and healthcare accessibility. As awareness of genetic disorders rises, more individuals seek testing, thereby expanding the market. The genetic testing market is expected to grow at a CAGR of approximately 15% over the next five years, reflecting the urgent need for effective diagnostic solutions.

### Growing Interest in Preventive Healthcare

The shift towards preventive healthcare is becoming increasingly prominent in India, driving the genetic testing market. Individuals are becoming more proactive about their health, seeking genetic tests to assess their risk for various diseases. This trend is supported by a growing body of evidence linking genetic predispositions to health outcomes. As more people recognize the value of preventive measures, the demand for genetic testing is likely to rise. The market is projected to see a growth rate of around 12% annually as consumers prioritize health management and disease prevention through genetic insights.

### Increased Collaboration Between Healthcare Providers and Genetic Testing Companies

Collaborative efforts between healthcare providers and genetic testing companies are fostering growth in the genetic testing market. Partnerships are being formed to integrate genetic testing into routine healthcare practices, enhancing patient care. These collaborations facilitate the sharing of knowledge and resources, leading to improved testing services and patient outcomes. As healthcare professionals become more familiar with genetic testing, they are more likely to recommend these services to patients. This trend is expected to drive market growth, as the integration of genetic testing into standard healthcare practices becomes more prevalent.

## Future Outlook

The [Genetic Testing Market](https://www.marketresearchfuture.com/reports/genetic-testing-market-2009) in India is projected to grow at 18.82% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare awareness, and rising demand for personalized medicine.

**New opportunities:**

- Expansion of telehealth services for genetic counseling Development of affordable at-home genetic testing kits Partnerships with healthcare providers for integrated testing solutions

By 2035, the genetic testing market is expected to be robust, driven by innovation and increased accessibility.

## Segment Insights

### By Application: Prenatal Testing (Largest) vs. Newborn Screening (Fastest-Growing)

The application segment of the India genetic testing market is characterized by a diverse range of testing types, with Prenatal Testing capturing the largest market share. This segment is significantly driven by increasing awareness and acceptance of genetic conditions by prospective parents. Meanwhile, Newborn Screening is quickly gaining traction due to the growing emphasis on early detection and prevention of genetic disorders in infants, positioning it as the fastest-growing segment within this landscape.

Growth trends in this segment are propelled by advancements in technology, rising healthcare expenditure, and a shift towards personalized medicine. As public awareness of genetic disorders increases, demand for diagnostic services is expected to surge, further bolstering the need for Carrier Testing, Diagnostic Testing, and Predictive Testing. The increasing prevalence of hereditary conditions coupled with government initiatives for screening programs contributes to the overall expansion of the market.

Prenatal Testing (Dominant) vs. Carrier Testing (Emerging)

Prenatal Testing stands as the dominant application within the India genetic testing market, mainly due to its crucial role in providing expectant parents with insights regarding potential genetic disorders in the fetus. The segment enjoys widespread adoption fueled by societal pressures and heightened awareness surrounding prenatal health. In contrast, Carrier Testing, although emerging, is gaining momentum as more couples opt for genetic assessments before conception. This testing serves to identify individuals who carry genes for certain inherited conditions, enabling informed family planning decisions. As genetic literacy rises and more healthcare providers promote such tests, both testing categories are expected to play significant roles in enhancing the understanding and management of genetic disorders in the population.

### By Type: Panel Tests (Largest) vs. Whole Genome Sequencing (Fastest-Growing)

In the India genetic testing market, the distribution of market share among the segment values is characterized by a notable dominance of Panel Tests, which have gained significant traction due to their comprehensive nature. These tests are favored for their ability to analyze multiple genes simultaneously, catering to a wide array of genetic disorders. In contrast, Whole Genome Sequencing, while currently possessing a smaller market share, is rapidly gaining attention as an innovative alternative, appealing to consumers eager for extensive genetic insights.

Growth trends within this segment are being driven by advancements in technology and an increasing consumer awareness about genetic health. Panel Tests are benefiting from improving accuracy and declining costs, making them more accessible to healthcare providers and patients alike. Meanwhile, the rise of Whole Genome Sequencing aligns with the growing demand for personalized medicine, with its capability to offer in-depth information that can influence treatment decisions, thus classifying it as the fastest-growing segment in the India genetic testing market.

Panel Tests (Dominant) vs. Whole Genome Sequencing (Emerging)

Panel Tests serve as the dominant force in the segment, widely appreciated for their efficiency in diagnosing a variety of genetic conditions through targeted gene analysis. Their established usage in clinical routines has solidified their position, making them the preferred choice for both patients and healthcare practitioners. In contrast, Whole Genome Sequencing, though emerging and currently less utilized, shows immense potential for transformative applications in genomics. As technology evolves, this segment is likely to witness rapid adoption, driven by its ability to provide a comprehensive landscape of an individual's genetic code, paving the way for personalized treatment and preventive health strategies.

### By Service Type: Laboratory Services (Largest) vs. Consultation Services (Fastest-Growing)

In the India genetic testing market, the market share distribution shows that Laboratory Services holds the largest share, reflecting the significant reliance on these services for accurate and efficient testing. Diagnostic Services also play a vital role, catering to a diverse range of genetic tests, whereas Consultation Services, although smaller in market share, are gaining traction due to increased awareness and demand for personalized medical advice.

Growth trends indicate that the Consultation Services segment is emerging as the fastest-growing area, driven by evolving healthcare needs and a shift towards personalized genetic insights. The integration of advanced technology within Diagnostic Services is further propelling their growth, making them more accessible and efficient. As patients become more informed, the demand for these services is expected to rise, creating new opportunities in the market.

Laboratory Services (Dominant) vs. Consultation Services (Emerging)

Laboratory Services are established as a dominant force in the genetic testing landscape, characterized by their comprehensive range of testing offerings and established infrastructure. These services ensure precision and reliability, making them the preferred choice for many healthcare professionals. On the other hand, Consultation Services are marked as emerging, primarily driven by the increasing demand for genetic counseling and tailored advice for patients. This segment focuses on educating patients and guiding them through their genetic testing options, which is becoming increasingly essential as public awareness grows about genetic disorders. As such, the interplay between these two segments reflects the evolving dynamics of the genetic testing market, with each playing a crucial role in shaping patient outcomes.

### By End User: Hospitals (Largest) vs. Clinical Laboratories (Fastest-Growing)

In the India genetic testing market, hospitals represent the largest share of the end-user segment, capitalizing on their integrated healthcare delivery systems and comprehensive patient care. This segment is characterized by advanced infrastructure and a widespread adoption of genetic testing for diagnostics and personalized medicine, driving a significant proportion of market activities. Clinical laboratories, on the other hand, are rapidly gaining traction, reflecting a growing demand for precise and timely genetic testing services. Their ability to specialize in various tests makes them a preferred choice for many healthcare providers and patients alike.

Growth trends within this segment are heavily influenced by technological advancements and an increasing focus on precision medicine. Rising awareness around genetic disorders and preventive healthcare is propelling the demand for genetic testing across hospitals and clinical laboratories. Moreover, research institutions contribute to innovation in testing methodologies, further stimulating market growth. The emergence of homecare settings also indicates a shift towards personalized and accessible genetic testing solutions, catering to patient convenience and preferences.

Hospitals (Dominant) vs. Clinical Laboratories (Emerging)

Hospitals in the India genetic testing market dominate due to their vast patient base and comprehensive medical services, allowing for an integrated approach to genetic testing within their healthcare frameworks. They leverage advanced technologies and skilled personnel to conduct a wide range of genetic tests for both diagnostic and therapeutic purposes, ensuring high accuracy and reliability. Conversely, clinical laboratories are emerging rapidly, focusing on specialized genetic tests that cater to niche markets. Their flexibility in adapting to new testing technologies and methods positions them well to meet the growing demand for genetic analysis in various healthcare scenarios. As patients seek more personalized care, both segments are poised to play crucial roles in shaping the future of genetic testing.

## Competitive Benchmarking

The genetic testing market in India is characterized by a rapidly evolving competitive landscape, driven by advancements in technology, increasing consumer awareness, and a growing emphasis on personalized medicine. Key players such as Illumina (US), Thermo Fisher Scientific (US), and Myriad Genetics (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market presence. Illumina (US) focuses on expanding its genomic sequencing capabilities, while Thermo Fisher Scientific (US) emphasizes the integration of digital solutions into its testing processes. Myriad Genetics (US) is strategically positioning itself through collaborations with healthcare providers to improve access to genetic testing services, thereby shaping a competitive environment that prioritizes technological advancement and customer-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they drive innovation and set industry standards. This competitive structure fosters an environment where smaller firms may struggle to keep pace with the rapid advancements and resource capabilities of larger entities.

In October  Illumina (US) announced a partnership with a leading Indian healthcare provider to enhance access to genomic testing in rural areas. This strategic move is likely to expand Illumina's footprint in the Indian market, addressing the critical need for accessible genetic testing services. By focusing on underserved regions, Illumina (US) not only enhances its market share but also contributes to the broader goal of improving healthcare outcomes in India.

In September  Thermo Fisher Scientific (US) launched a new suite of genetic testing products tailored specifically for the Indian market. This initiative reflects the company's commitment to innovation and localization, as it aims to meet the unique needs of Indian consumers. The introduction of these products is expected to strengthen Thermo Fisher's competitive position by providing tailored solutions that resonate with local healthcare providers and patients.

In August  Myriad Genetics (US) expanded its genetic testing portfolio by introducing a new hereditary cancer test in India. This expansion is strategically significant as it aligns with the increasing demand for personalized medicine and early detection of genetic predispositions. By enhancing its offerings, Myriad Genetics (US) positions itself as a leader in the hereditary testing space, potentially capturing a larger share of the market as awareness of genetic testing continues to grow.

As of November  current trends in the genetic testing market include a strong focus on digitalization, sustainability, and the integration of artificial intelligence (AI) into testing processes. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, it appears that competitive differentiation will increasingly hinge on technological advancements and supply chain reliability, rather than solely on price. Companies that prioritize innovation and customer-centric solutions are likely to thrive in this dynamic market.

## Recent News & Developments

The India Genetic Testing Market has witnessed notable advancements, particularly with the increasing integration of advanced technologies in diagnostic tools. Companies like LabCorp and Thermo Fisher Scientific are enhancing their capabilities to meet the rise in consumer demand for genetic tests driven by the growing prevalence of genetic disorders. In August 2023, MedGenome raised significant funding to expand its genetic testing services, which is expected to bolster their market presence.

Furthermore, in June 2023, Roche announced a collaboration with Narayana Health to offer advanced genetic testing solutions in India, enhancing accessibility for patients. The market has also seen substantial growth in valuation as the Indian government focuses on improving healthcare infrastructure and personalized medicine initiatives. In 2021, Mylab Discovery Solutions launched a new range of genetic tests, aligning with the increasing emphasis on preventive healthcare. Companies like Mapmygenome and Qiagen are also stepping up their product offerings, capitalizing on India's expanding healthcare market.

As of October 2023, the sector continues to flourish, reflecting an overall optimistic outlook driven by innovation and strategic partnerships among key players in this dynamic environment.

## Report Scope

| MARKET SIZE 2024 | 665.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 790.15(USD Million) |
| MARKET SIZE 2035 | 4432.15(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 18.82% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Illumina (US), Thermo Fisher Scientific (US), Myriad Genetics (US), 23andMe (US), Genomic Health (US), Fulgent Genetics (US), Natera (US), Guardant Health (US) |
| Segments Covered | Application, Type, Service Type, End User |
| Key Market Opportunities | Advancements in personalized medicine drive demand for innovative solutions in the genetic testing market. |
| Key Market Dynamics | Rising consumer awareness drives demand for genetic testing, influencing regulatory frameworks and competitive strategies in the market. |
| Countries Covered | India |

## Frequently Asked Questions

**Q: What is the current valuation of the genetic testing market in India as of 2024?**
A: The overall market valuation was $665.0 Million in 2024.

**Q: What is the projected market valuation for the genetic testing market in India by 2035?**
A: The projected valuation for 2035 is $4432.15 Million.

**Q: What is the expected CAGR for the genetic testing market in India during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during this period is 18.82%.

**Q: Which application segment had the highest valuation in 2024 within the genetic testing market in India?**
A: Diagnostic Testing had the highest valuation at $200.0 Million in 2024.

**Q: What is the valuation range for Newborn Screening in the genetic testing market in India?**
A: The valuation range for Newborn Screening is from $150.0 Million to $900.0 Million.

**Q: Which type of genetic testing is projected to have the highest valuation by 2035?**
A: Whole Exome Sequencing is projected to have the highest valuation by 2035.

**Q: What are the key players currently leading the genetic testing market in India?**
A: Key players include Illumina, Thermo Fisher Scientific, Myriad Genetics, and 23andMe.

**Q: What is the valuation range for Carrier Testing in the genetic testing market in India?**
A: The valuation range for Carrier Testing is from $120.0 Million to $800.0 Million.

**Q: Which end user segment is expected to show significant growth in the genetic testing market in India?**
A: Clinical Laboratories are expected to show significant growth, with a valuation range of $250.0 Million to $1500.0 Million.

**Q: What is the projected valuation for Non-Invasive Prenatal Testing by 2035?**
A: The projected valuation for Non-Invasive Prenatal Testing is expected to reach $400.0 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-genetic-testing-market-44951*